Trials / Completed
CompletedNCT01069848
Feasibility Study of the Vedera KXS for Treatment of Keratoconus
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 23 (actual)
- Sponsor
- Glaukos Corporation · Industry
- Sex
- All
- Age
- 14 Years – 100 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this investigation is to evaluate the feasibility, safety and efficacy of the Vedera KXS for the reduction or elimination of myopia and astigmatism in patients with keratoconus, who are no longer able to achieve adequate vision with their contact lenses or glasses.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Vedera KXS | One treatment session with Vedera KXS |
Timeline
- Start date
- 2010-01-01
- Primary completion
- 2011-03-01
- Completion
- 2011-03-01
- First posted
- 2010-02-17
- Last updated
- 2021-04-26
Locations
1 site across 1 country: Turkey (Türkiye)
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT01069848. Inclusion in this directory is not an endorsement.